ウィキペディア |
 
|
不眠症
出典: フリー百科事典『ウィキペディア（Wikipedia）』 (2012/02/07 11:55 UTC 版)
(睡眠不足 から転送)
不眠症 (ふみんしょう,英:Insomnia) とは、個人が睡眠困難を訴えている状況と定義される[1]。
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
- ^ 。この用語は睡眠についての文献では、睡眠障害のエビデンスとしてポリグラフにて "Do you experience difficulty sleeping?" or "Do you have difficulty falling or staying asleep?"といった2つの質問に対し肯定反応を返した場合として定義される
- ^ Signs of Insomnia.
- ^ Hirshkowitz, Max (2004). “Chapter 10, Neuropsychiatric Aspects of Sleep and Sleep Disorders (pp 315-340)”. In Stuart C. Yudofsky and Robert E. Hales, editors (Google Books preview includes entire chapter 10). Essentials of neuropsychiatry and clinical neurosciences (4版). Arlington, Virginia, USA: American Psychiatric Publishing. ISBN 9781585620050 2009年12月6日閲覧. "...insomnia is a symptom. It is neither a disease nor a specific condition. (from p. 322)"
- ^ Morin, Charles M. (2000). “The Nature of Insomnia and the Need to Refine Our Diagnostic Criteria” (Editorial)Psychosomatic Medicine 62 (4): 62:483?485. PMID 10949092. 2010年1月7日閲覧。
- ^ a b c d e http://www.e-healthnet.mhlw.go.jp/information/heart/k-02-001.html 不眠症 厚生労働省]
- ^ 薬物に関連する睡眠障害
- ^ Harrison C, Britt H (2009). "Insomnia". Australian Family Physician, 32:283. Available at http://www.racgp.org.au/afp/200905/200905beach.pdf and http://www.nps.org.au/news_and_media/media_releases/repository/New_clinical_program_addresses
- ^ Glass J, Lanctot KL, Herrmann N, Sproule BA, Busto UE (2005 November). “Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits”. BMJ 331 (7526): 1169. doi:10.1136/bmj.38623.768588.47. PMID 16284208. PMC 1285093.
- ^ Rosenberg, RP. (2006 Jan-Mar). “Sleep maintenance insomnia: strengths and weaknesses of current pharmacologic therapies”Ann Clin Psychiatry 18 (1): 49?56. doi:10.1080/10401230500464711. PMID 16517453.
- ^ a b Buscemi N, Vandermeer B, Friesen C, Bialy L, Tubman M, Ospina M, Klassen TP, Witmans M. (2007 September). “The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs”. J Gen Intern Med 22 (9): 1335–1350. doi:10.1007/s11606-007-0251-z. PMID 17619935. PMC 2219774.
- ^ Ohayon MM, Caulet M (1995 May). “Insomnia and psychotropic drug consumption”. Prog. Neuropsychopharmacol. Biol. Psychiatry 19 (3): 421?31. doi:10.1016/0278-5846(94)00023-B. PMID 7624493.
- ^ (2004 December). “What's wrong with prescribing hypnotics”Drug Ther Bull 42 (12): 89?93. doi:10.1136/dtb.2004.421289. PMID 15587763.
- ^ [1]
- ^ Tsoi, Wf (1991 March). “Insomnia: drug treatment”. Annals of the Academy of Medicine, Singapore 20 (2): 269?72. ISSN 0304-4602. PMID 1679317.
- ^ Montplaisir J (2000 August). “Treatment of primary insomnia” (PDF). CMAJ 163 (4): 389?91. PMID 10976252. PMC 80369.
- ^ D. Maiuro PhD, Roland (13 December 2009). Handbook of Integrative Clinical Psychology, Psychiatry, and Behavioral Medicine: Perspectives, Practices, and Research. Springer Publishing Company. pp. 128?130. ISBN 0-8261-1094-0.
- ^ Lader, Malcolm Harold; P. Cardinali, Daniel; R. Pandi-Perumal, S. (22 March 2006). Sleep and sleep disorders: a neuropsychopharmacological approach. Georgetown, Tex.: Landes Bioscience/Eurekah.com. p. 127. ISBN 0-387-27681-5.
- ^ Authier, N.; Boucher, A.; Lamaison, D.; Llorca, PM.; Descotes, J.; Eschalier, A. (2009). “Second Meeting of the French CEIP (Centres d'Evaluation et d'Information sur la Pharmacodependance). Part II: Benzodiazepine Withdrawal”Therapie 64 (6): 365?370. doi:10.2515/therapie/2009051. PMID 20025839.
- ^ WHO (2006年). “World Health Organisation - Assessment of Zopiclone (PDF)”. who.int. 2011年12月閲覧。
- ^ Rowlett JK, Woolverton WL (1996 November). “Assessment of benzodiazepine receptor heterogeneity in vivo: apparent pA2 and pKB analyses from behavioral studies” (PDF). Psychopharmacology (Berl.) 128 (1): 1?16. doi:10.1007/s002130050103. PMID 8944400.
- ^ Noguchi H, Kitazumi K, Mori M, Shiba T. (2004 March). “Electroencephalographic properties of zaleplon, a non-benzodiazepine sedative/hypnotic, in rats” (pdf). J Pharmacol Sci. 94 (3): 246?51. doi:10.1254/jphs.94.246. PMID 15037809.
- ^ Bertschy G, Ragama-Pardos E, Muscionico M, et al (2005 January). “Trazodone addition for insomnia in venlafaxine-treated, depressed inpatients: a semi-naturalistic study”. Pharmacol. Res. 51 (1): 79?84. doi:10.1016/j.phrs.2004.06.007. PMID 15519538.
- ^ Winokur A, DeMartinis NA 3rd, McNally DP, Gary EM, Cormier JL, Gary KA. , et al (2003 August pmid=14658972). “Comparative effects of mirtazapine and fluoxetine on sleep physiology measures in patients with major depression and insomnia”. J Clin Psychiatry.
- ^ Schittecatte M, Dumont F, Machowski R, Cornil C, Lavergne F, Wilmotte J , et al (2002). “Effects of mirtazapine on sleep polygraphic variables in major depression”. Neuropsychobiology 46 (4): 197-201. doi:10.1159/000067812. PMID 12566938.
- ^ Buscemi, N.; Vandermeer, B.; Hooton, N.; Pandya, R.; Tjosvold, L.; Hartling, L.; Vohra, S.; Klassen, T. P. et al. (2006). “Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: Meta-analysis”BMJ 332 (7538): 385?393. doi:10.1136/bmj.38731.532766.F6. PMID 16473858. PMC 1370968.
- ^ 日本医師会 『漢方治療のABC (日本医師会生涯教育シリーズ)』 日本医師会、1992年。ISBN 978-4260175074。
- ^ Donath F, Quispe S, Diefenbach K, Maurer A, Fietze I, Roots I (2000). “Critical evaluation of the effect of valerian extract on sleep structure and sleep quality”. Pharmacopsychiatry 33 (2): 47?53. doi:10.1055/s-2000-7972. PMID 10761819.
- ^ Morin CM, Koetter U, Bastien C, Ware JC, Wooten V (2005). “Valerian-hops combination and diphenhydramine for treating insomnia: a randomized placebo-controlled clinical trial”. Sleep 28 (11): 1465?71. PMID 16335333.
- ^ Meolie AL, Rosen C, Kristo D, et al (2005). “Oral nonprescription treatment for insomnia: an evaluation of products with limited evidence”. Journal of Clinical Sleep Medicine 1 (2): 173?87. PMID 17561634.
- ^ Hornyak M, Voderholzer U, Hohagen F, Berger M, Riemann D (1998). “Magnesium therapy for periodic leg movements-related insomnia and restless legs syndrome: an open pilot study”. Sleep 21 (5): 501?5. PMID 9703590.
- ^ Billiard, M, Kent, A (2003). Sleep: physiology, investigations, medicine. pp. 275?7. ISBN 9780306474064.
- ^ Yamadera W, Inagawa K, Chiba S, Bannai M, Takahashi M, Nakayama K (2007). “Glycine ingestion improves subjective sleep quality in human volunteers, correlating with polysomnographic changes”. Sleep and Biological rhythms 5 (2): 126?131. doi:10.1111/j.1479-8425.2007.00262.x.
[続きの解説]
睡眠不足に関係した商品
- [不眠対策][睡眠不足解消][寝不足対策][入眠補助機器][快眠]【送料無料（※北海道・沖縄は525円）】NightWave（ナイトウェーブ）睡眠不足対策！すみやかな眠りを【国内正規品】【smtb-k】【楽ギフ_包装選択】タイムクラブ
- ギャバ GABA γ-アミノ酪酸 アミノ酸 高濃度 天然 睡眠不足 不眠 倦怠感 更年期障害 ダイエット 生活習慣病 栄養補助食品 サプリ サプリメント◆ギャバ太郎 スーパー50 お徳用3ヶ月分 30粒×3袋セット◆ ギャバ/GABA/γ-アミノ酪酸/アミノ酸/高濃度/天然/睡眠不足/不眠/倦怠感/更年期障害/ダイエット/生活習慣病/栄養補助食品/サプリ/サプリメントギャバ太郎ショップ
- 睡眠不足解消 マッサージ枕ぐっすり〜2睡眠不足解消 マッサージ枕ぐっすり〜2KusuKusu Mart
睡眠不足のページへのリンク
